Development and evaluation of a dipstick diagnostic test for neisseria meningitidis serogroup X

Journal of Clinical Microbiology

Volumn 53, Issue 2, 2015, Pages 449-454

  Agnememel, Alain ^a,b   Traincard, François ^a   Dartevelle, Sylvie ^a   Mulard, Laurence ^a   Mahamane, Ali Elhaji ^c   Oukem Boyer, Odile Ouwe Missi ^c   Denizon, Mélanie ^a   Kacou N'Douba, Adèle ^d   Dosso, Mireille ^d   Gake, Bouba ^e   Lombart, Jean Pierre ^e   Tahaa, Muhamed Kheir ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Centre de Recherche Medicale et Sanitaire Niamey   (Niger)

^d INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^e Centre Pasteur Annexe de Garoua   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CAPSULAR POLYSACCHARIDE; POLYSACCHARIDE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PURIFICATION; ARTICLE; BACTERIAL STRAIN; CAMEROON; CEREBROSPINAL FLUID ANALYSIS; COLONY FORMING UNIT; CONTROLLED STUDY; COTE D'IVOIRE; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIPSTICK RAPID DIAGNOSTIC TEST; FEMALE; FRANCE; IMMUNOAFFINITY CHROMATOGRAPHY; KAPPA STATISTICS; LIMIT OF DETECTION; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; NIGER; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREVALENCE; SENSITIVITY AND SPECIFICITY; AFRICA; CEREBROSPINAL FLUID; EVALUATION STUDY; HUMAN; ISOLATION AND PURIFICATION; MENINGITIS, MENINGOCOCCAL; MICROBIOLOGY; PROCEDURES; SEROTYPE;

NEISSERIA MENINGITIDIS; ORYCTOLAGUS CUNICULUS;

AFRICA; ANTIGENS, BACTERIAL; CEREBROSPINAL FLUID; DIAGNOSTIC TESTS, ROUTINE; FRANCE; HUMANS; IMMUNOCHROMATOGRAPHY; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; PREDICTIVE VALUE OF TESTS; SEROGROUP;

EID: 84921823554     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02444-14     Document Type: Article

References (26)

1. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. 2001. Meningococcal disease. N Engl J Med 344:1378-1388. http://dx.doi.org/10.1056/NEJM200105033441807.
2. Harrison LH, Pelton SI, Wilder-Smith A, Holst J, Safadi MA, Vazquez JA, Taha MK, LaForce FM, von Gottberg A, Borrow R, Plotkin SA. 2011. The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine 29:3363-3371. http://dx.doi.org/10.1016/j.vaccine.2011.02.058.
3. Harrison LH, Trotter CL, Ramsay ME. 2009. Global epidemiology of meningococcal disease. Vaccine 27(Suppl 2):B51-B63. http://dx.doi.org/10.1016/j.vaccine.2009.04.063.
4. O'Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM. 2014. A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program. Drugs 74:15-30. http://dx.doi.org/10.1007/s40265-013-0155-7.
5. Hong E, Giuliani MM, Deghmane AE, Comanducci M, Brunelli B, Dull P, Pizza M, Taha MK. 2013. Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa? Vaccine 31:1113-1116. http://dx.doi.org/10.1016/j.vaccine.2012.12.022.
6. Frasch CE, Preziosi MP, LaForce FM. 2012. Development of a group A meningococcal conjugate vaccine, MenAfriVac. Hum Vaccin Immu-nother 8:715-724. http://dx.doi.org/10.4161/hv.19619.
7. Boisier P, Nicolas P, Djibo S, Taha MK, Jeanne I, Maïnassara HB, Tenebray B, Kairo KK, Giorgini D, Chanteau S. 2007. Meningococcal meningitis: unprecedented incidenceof serogroup X-related cases in 2006 in Niger. Clin Infect Dis 44:657-663. http://dx.doi.org/10.1086/511646.
8. Taha MK, Parent Du Chatelet I, Schlumberger M, Sanou I, Djibo S, de Chabalier F, Alonso JM. 2002. Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 40: 1083-1084. http://dx.doi.org/10.1128/JCM.40.3.1083-1084.2002.
9. Collard JM, Issaka B, Zaneidou M, Hugonnet S, Nicolas P, Taha MK, Greenwood B, Jusot JF. 2013. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination. BMC Infect Dis 13:576. http://dx.doi.org/10.1186/1471-2334-13-576.
10. Terrade A, Collard JM, Nato F, Taha MK. 2013. Laboratory evaluation of a rapid diagnostic test for Neisseria meningitidis serogroup A. Trans R Soc Trop Med Hyg 107:460-461. http://dx.doi.org/10.1093/trstmh/trt041.
11. Chanteau S, Sidikou F, Djibo S, Moussa A, Mindadou H, Boisier P. 2006. Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger. Trans R Soc Trop Med Hyg 100:677-680. http://dx.doi.org/10.1016/j.trstmh.2005.09.006.
12. Chanteau S, Dartevelle S, Mahamane AE, Djibo S, Boisier P, Nato F. 2006. New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y. PLoS Med 3:e337. http://dx.doi.org/10.1371/journal.pmed.0030337.
13. European Centre for Disease Prevention and Control. 2013. Annual epidemiological report: reporting on 2010 surveillance data and 2011 epidemic intelligence data, 2012. European Centre for Disease Prevention and Control, Stockholm, Sweden. http://ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological-Report-2012.pdf.
14. Micoli F, Romano MR, Tontini M, Cappelletti E, Gavini M, Proietti D, Rondini S, Swennen E, Santini L, Filippini S, Balocchi C, Adamo R, Pluschke G, Norheim G, Pollard A, Saul A, Rappuoli R, MacLennan CA, Berti F, Costantino P. 2013. Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proc Natl Acad Sci USA 110:19077-19082. http://dx.doi.org/10.1073/pnas.1314476110.
15. Kellogg DS, Jr, Peacock WL, Jr, Deacon WE, Brown L, Pirkle DI. 1963. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J Bacteriol 85:1274-1279.
16. Ballard TL, Roe MH, Wheeler RC, Todd JK, Glode MP. 1987. Comparison of three latex agglutination kits and counterimmunoelectrophoresis for the detection of bacterial antigens in a pediatric population. Pediatr Infect Dis J 6:630-634. http://dx.doi.org/10.1097/00006454-198707000-00003.
17. Abdillahi H, Poolman JT. 1988. Neisseria meningitidis group B serosub-typing using monoclonal antibodies in whole-cell ELISA. Microb Pathog 4:27-32. http://dx.doi.org/10.1016/0882-4010(88)90045-9.
18. Parent du Châtelet I, Traore Y, Gessner BD, Antignac A, Naccro B, Njanpop-Lafourcade BM, Ouedraogo MS, Tiendrebeogo SR, Varon E, Taha MK. 2005. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis 40:17-25. http://dx.doi.org/10.1086/426436.
19. Nato F, Mazie JC, Fournier JM, Slizewicz B, Sagot N, Guibourdenche M, Postic D, Riou JY. 1991. Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents. J Clin Microbiol 29:1447-1452.
20. Xie O, Bolgiano B, Gao F, Lockyer K, Swann C, Jones C, Delrieu I, Njanpop-Lafourcade BM, Tamekloe TA, Pollard AJ, Norheim G. 2012. Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies. Vaccine 30:5812-5823. http://dx.doi.org/10.1016/j.vaccine.2012.07.032.
21. Taha MK, Giorgini D. 1995. Phosphorylation and functional analysis of PilA, a protein involved in the transcriptional regulation of the pilin gene in Neisseria gonorrhoeae. Mol Microbiol 15:667-677.
22. Chanteau S, Rahalison L, Ralafiarisoa L, Foulon J, Ratsitorahina M, Ratsifasoamanana L, Carniel E, Nato F. 2003. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet 361: 211-216. http://dx.doi.org/10.1016/S0140-6736(03)12270-2.
23. Jaeschke R, Guyatt GH, Sackett DL. 1994. Users' guides to the medical literature. III. How to useanarticle about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271:703-707.
24. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. 2003. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129-1135. http://dx.doi.org/10.1016/S0895-4356(03)00177-X.
25. Cohen J. 1960. A coefficient of agreement for nominal scales. Edu Psychol Measur 20:37-46. http://dx.doi.org/10.1177/001316446002000104.
26. Cartwright KA, Reilly S, White D, Stuart J. 1992. Early treatment with parenteral penicillin in meningococcal disease. BMJ 305:143-147. http://dx.doi.org/10.1136/bmj.305.6846.143.